secwatch.observer — SEC 8-K summary
======================================

Issuer:     Equillium, Inc. (EQ)
CIK:        0001746466
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001193125-24-182856
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Equillium receives Nasdaq bid price deficiency notice; cure deadline Jan 15, 2025
--------------------------------------------------------------------------------

- Received Nasdaq notice on July 19, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has 180-day grace period until Jan 15, 2025 to regain compliance by closing at $1.00+ for ten consecutive days.
- If not cured, may qualify for additional 180-day period if meeting other initial listing standards.
- Company will consider options including a reverse stock split to cure the bid price deficiency.
- Common stock continues to trade on Nasdaq Capital Market under symbol 'EQ' with no immediate effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746466/000119312524182856/0001193125-24-182856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746466/000119312524182856/d858010d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-182856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer